Literature DB >> 12482139

EBV viral load monitoring: unanswered questions.

Michael Green, Steven A Webber.   

Abstract

Mesh：

Year:  2002        PMID： 12482139     DOI： 10.1034/j.1600-6143.2002.21003.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  6 in total

1.  EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.

Authors:  Camila Macedo; Steven A Webber; Albert D Donnenberg; Iulia Popescu; Yun Hua; Michael Green; David Rowe; Louise Smith; Maria M Brooks; Diana Metes
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

Review 2.  Posttransplant lymphoproliferative disease: pathogenesis, monitoring, and therapy.

Authors:  Richard F Ambinder
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

3.  Chronic high Epstein-Barr viral load carriage in pediatric small bowel transplant recipients.

Authors:  Audrey H Lau; Kyle Soltys; Rakesh K Sindhi; Geoffrey Bond; George V Mazariegos; Michael Green
Journal:  Pediatr Transplant       Date:  2010-01-20

4.  A Rare Case of Classical Hodgkin Lymphoma Diagnosed 10 Years after Liver Transplant.

Authors:  L Zhang; R Pereira Mestre; F Bihl; M Bühler; B Vannata; A Stathis
Journal:  Case Rep Oncol       Date:  2017-10-17

5.  Long-lasting chronic high load carriage of Epstein-Barr virus is more common in young pediatric renal transplant recipients.

Authors:  Susanne Westphal Ladfors; Jenny K Lindahl; Sverker Hansson; Per Brandström; Rune Andersson; Marianne Jertborn; Magnus Lindh; Susanne Woxenius; Vanda Friman
Journal:  Pediatr Nephrol       Date:  2019-12-04       Impact factor: 3.714

Review 6.  Life-threatening infection in transplant recipients.

Authors:  Daire T O'Shea; Atul Humar
Journal:  Crit Care Clin       Date:  2013-08-08       Impact factor: 3.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.